BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37330691)

  • 1. N-Butyl Cyanoacrylate Glue Versus Nonspherical Polyvinyl Alcohol Particles For Prostatic Arterial Embolization To Treat Benign Prostatic Hyperplasia: Safety and Efficacy.
    Hijazi BA; Shi HB; Liu S; Alqurashi TA; Sabri ZJ
    Urol J; 2023 Jul; 20(4):261-268. PubMed ID: 37330691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Clinical Outcomes of Prostatic Artery Embolization with 50-μm Plus 100-μm Polyvinyl Alcohol (PVA) Particles versus 100-μm PVA Particles Alone: A Prospective Randomized Trial.
    Wang MQ; Zhang JL; Xin HN; Yuan K; Yan J; Wang Y; Zhang GD; Fu JX
    J Vasc Interv Radiol; 2018 Dec; 29(12):1694-1702. PubMed ID: 30297313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Nonspherical Polyvinyl Alcohol Particles and Microspheres for Prostatic Arterial Embolization in Patients with Benign Prostatic Hyperplasia.
    Hwang JH; Park SW; Chang IS; Jung SI; Jeon HJ; Lho YS; Kim HG; Paick SH; Park HK
    Biomed Res Int; 2017; 2017():8732351. PubMed ID: 28717651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study.
    Bilhim T; Pisco J; Campos Pinheiro L; Rio Tinto H; Fernandes L; Pereira JA; Duarte M; Oliveira AG
    J Vasc Interv Radiol; 2013 Nov; 24(11):1595-602.e1. PubMed ID: 23916874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: A six-month outcome analysis in 103 patients.
    Loffroy R; Quirantes A; Guillen K; Mazit A; Comby PO; Aho-Glélé LS; Chevallier O
    Diagn Interv Imaging; 2024 Apr; 105(4):129-136. PubMed ID: 38161141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement.
    Bilhim T; Pisco J; Rio Tinto H; Fernandes L; Campos Pinheiro L; Duarte M; Pereira JA; Oliveira AG; O'Neill J
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):403-11. PubMed ID: 23232858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic Arterial Embolization with Small Sized Particles for the Treatment of Lower Urinary Tract Symptoms Due to Large Benign Prostatic Hyperplasia: Preliminary Results.
    Li Q; Duan F; Wang MQ; Zhang GD; Yuan K
    Chin Med J (Engl); 2015 Aug; 128(15):2072-7. PubMed ID: 26228221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population.
    Wang MQ; Guo LP; Zhang GD; Yuan K; Li K; Duan F; Yan JY; Wang Y; Kang HY; Wang ZJ
    BMC Urol; 2015 Apr; 15():33. PubMed ID: 25887036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia.
    Somwaru AS; Metting S; Flisnik LM; Nellamattathil MG; Sharma A; Katabathina VS
    BMC Urol; 2020 Oct; 20(1):153. PubMed ID: 33032577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period.
    Bilhim T; Costa NV; Torres D; Pinheiro LC; Spaepen E
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1324-1336. PubMed ID: 35778579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up.
    Pisco JM; Rio Tinto H; Campos Pinheiro L; Bilhim T; Duarte M; Fernandes L; Pereira J; Oliveira AG
    Eur Radiol; 2013 Sep; 23(9):2561-72. PubMed ID: 23370938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia.
    Pisco JM; Bilhim T; Costa NV; Torres D; Pisco J; Pinheiro LC; Oliveira AG
    Eur Urol; 2020 Mar; 77(3):354-362. PubMed ID: 31831295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.
    Insausti I; Sáez de Ocáriz A; Galbete A; Capdevila F; Solchaga S; Giral P; Bilhim T; Isaacson A; Urtasun F; Napal S
    J Vasc Interv Radiol; 2020 Jun; 31(6):882-890. PubMed ID: 32249193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic Artery Embolization Using 100-300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up.
    Ayyagari R; Powell T; Staib L; Chapiro J; Raja A; Bhatia S; Chai T; Schoenberger S; Devito R
    J Vasc Interv Radiol; 2020 Jan; 31(1):99-107. PubMed ID: 31771896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 5-Alpha-Reductase Inhibitors Use at the Time of Prostatic Artery Embolization for Treatment of Benign Prostatic Obstruction.
    Cardarelli-Leite L; de Assis AM; Moreira AM; Antunes AA; Cerri GG; Srougi M; Carnevale FC
    J Vasc Interv Radiol; 2019 Feb; 30(2):228-232. PubMed ID: 30717954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic Artery Embolization for Benign Prostatic Obstruction: Single-Centre Retrospective Study Comparing Microspheres Versus n-Butyl Cyanoacrylate.
    Salet E; Crombé A; Grenier N; Marcelin C; Lebras Y; Jambon E; Coussy A; Cornelis FH; Petitpierre F
    Cardiovasc Intervent Radiol; 2022 Jun; 45(6):814-823. PubMed ID: 35266024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results.
    Pisco J; Campos Pinheiro L; Bilhim T; Duarte M; Rio Tinto H; Fernandes L; Vaz Santos V; Oliveira AG
    Radiology; 2013 Feb; 266(2):668-77. PubMed ID: 23204546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.